Patents Assigned to University of Virginia Patent Foundation
-
Patent number: 11451261Abstract: Asynchronous stream generation and processing techniques are described that support implementation of an asynchronous stream mote in which one or more analog sensor signals are used to generate one or more asynchronous streams. On-device operations processing of the one or more asynchronous streams may be performed before transmission of the result(s) to other system components (e.g., peer motes or higher-level system components).Type: GrantFiled: July 24, 2020Date of Patent: September 20, 2022Assignee: University of Virginia Patent FoundationInventors: Mircea R. Stan, Luisa P. Gonzalez Guerrero
-
Publication number: 20220280543Abstract: Provided are methods for treating and/or preventing diseases, disorders, and/or conditions associated with NLR family CARD domain containing 4 (NLRC4) inflammasome biological activities. In some embodiments, the method include administering to a subject in need thereof a composition that includes a nucleoside reverse transcriptase inhibitor (NRTI). Also provided are methods for inhibiting NLRC4-induced caspase-1 activation in cells, methods for inhibiting NLRC4-induced IL-I? release from cells, methods for inhibiting Alu-induced retinal pigmented cell (RPE) degeneration in subjects, and compositions for use in the presently disclosed methods.Type: ApplicationFiled: August 24, 2020Publication date: September 8, 2022Applicant: University of Virginia Patent FoundationInventors: Jayakrishna Ambati, Shao-bin Wang, Kameshwari Ambati
-
Patent number: 11436714Abstract: Embodiments of the innovation relate to an emotional quality estimation device comprising a controller having a memory and a processor, the controller configured to execute a training engine with labelled training data to train a neural network and generate a classroom analysis machine, the labelled training data including historical video data and an associated classroom quality score table; receive a classroom observation video from a classroom environment; execute the classroom analysis machine relative to the classroom observation video from the classroom environment to generate an emotional quality score relating to the emotional quality of the classroom environment; and output the emotional quality score for the classroom environment.Type: GrantFiled: August 21, 2020Date of Patent: September 6, 2022Assignees: Worcester Polytechnic Institute, University of Virginia Patent FoundationInventors: Jacob Whitehill, Anand Ramakrishnan, Erin Ottmar, Jennifer LoCasale-Crouch
-
Patent number: 11436401Abstract: Transient voltage noise, including resistive and reactive noise, causes timing errors at runtime. A heuristic framework, Walking Pads, is introduced to minimize transient voltage violations by optimizing power supply pad placement. It is shown that the steady-state optimal design point differs from the transient optimum, and further noise reduction can be achieved with transient optimization. The methodology significantly reduces voltage violations by balancing the average transient voltage noise of the four branches at each pad site. When pad placement is optimized using a representative stressmark, voltage violations are reduced 46-80% across 11 Parsec benchmarks with respect to the results from IR-drop-optimized pad placement. It is shown that the allocation of on-chip decoupling capacitance significantly influences the optimal locations of pads.Type: GrantFiled: September 16, 2019Date of Patent: September 6, 2022Assignee: UNIVERSITY OF VIRGINIA PATENT FOUNDATIONInventors: Ke Wang, Kevin Skadron, Mircea R. Stan, Runjie Zhang
-
Patent number: 11436280Abstract: A method of approximating a maximum clique of a graph can be provided by operating a plurality of non-linear oscillator/coupling capacitor circuits connected to one another according to a respective plurality of degree-ordered subgraphs of the graph to provide respective candidate cliques for a maximum clique of the graph. Nodes in the graph that are connected to all of the nodes in each of the respective candidate cliques can be identified to provide respective expansion node subgraphs for the respective candidate cliques. The plurality of non-linear oscillator/coupling capacitor circuits connected to one another according to the respective expansion node subgraphs can be operated to provide respective expansion cliques for the respective candidate cliques and the respective expansion cliques can be added to the respective candidate cliques to identify a designated maximum clique for the graph.Type: GrantFiled: April 29, 2020Date of Patent: September 6, 2022Assignee: University of Virginia Patent FoundationInventors: Nikhil Shrikant Shukla, Mohammad Khairul Bashar, Antik Mallick
-
Publication number: 20220275387Abstract: The present technology provides transcription factors for modifying plant metabolism and nucleic acid molecules that encode such transcription factors. Also provide are methods of using these nucleic acids to modulate alkaloid production in plants and for producing plant and plant cells having altered alkaloid content. Disclosed herein are methods and compositions for modulating nicotine biosynthesis in plants.Type: ApplicationFiled: August 4, 2020Publication date: September 1, 2022Applicants: University of Virginia Patent Foundation, 22nd Century Limited, LLCInventors: Michael P. TIMKO, Hai Liu
-
Patent number: 11426371Abstract: The present application provides novel compositions and methods for treating acute myeloid leukemia (AML). Compounds of the invention are acid ceramidase inhibitors, reduce AML cell viability, inhibit AML cell proliferation, increase cell death of AML cells, and induce apoptosis in AML cells. A primary compound of the invention is SACLAC: 2-chloro-N-((2S,3R)-1,3-dihydroxyoctadecan-2-yl)acetamide. The bromine analog of SACLAC (SABRAC: 2-bromo-N-((2S,3R)-1,3-dihydroxyoctadecan-2-yl)acetamide) is also useful for treating AML. SACLAC has much better activity than other know drugs used to treat AML.Type: GrantFiled: April 27, 2018Date of Patent: August 30, 2022Assignees: University of Virginia Patent Foundation, Universität de Barcelona, Consejo Superior de Investigaciones Cientificas (CSIC)Inventors: Thomas P. Loughran, Jr., Gemma Fabrias, Jose Luis Abad, Josefina Casas, David J. Feith, Su-Fern Tan, Jennifer M. Pearson, Antonio Delgado Cirilo
-
Publication number: 20220265791Abstract: Provided are compositions that include one or more synthetic target peptides, wherein each synthetic target peptide is about or at least 8-50 amino acids long; and has an amino acid sequence as set forth in Table 2 and/or Table 3. Also provided are in vitro populations of dendritic cells that include the disclosed compositions, in vitro population of CD8+ T cells capable of being activated upon being brought into contact with the disclosed populations of dendritic cells, antibodies or antibody-like molecules that specifically binds to a complex of an MHC class I molecule and a peptide having an amino acid sequence as set forth in Table 2 and/or Table 3, methods for treating and/or preventing cancers by administering a therapeutically effective dose of a composition that includes at least one target peptide having an amino acid sequence as set forth in Table 2 and/or Table 3.Type: ApplicationFiled: July 21, 2020Publication date: August 25, 2022Applicants: University of Virginia Patent Foundation, The University of Birmingham, The General Hospital CorporationInventors: Donald F. Hunt, Jeffrey Shabanowitz, Keira Mahoney, Jennifer G. Abelin, Mohammad Ovais Azizzanjani, Paisley Trantham Myers, Stacy Alyse Malaker, Andrew Norris, Jennifer Hitchcock, Xi Peng, Negin Ghafourian, Mark Cobbold, Sarah Penny, Nico Buettner, James M. Heather
-
Publication number: 20220267373Abstract: Novel self-assembling pentapeptides and peptides containing such self-assembling pentapeptides, self-assembled hydrogels, and methods of making and using the same are described. These pentapeptides, and peptides containing such pentapeptides, self-assemble under physiological conditions (e.g., in a physiological buffer under biologically acceptable conditions (e.g., pH?6-11)) into long fibrils with sequence-dependent fibrillary morphologies. The hydrogels comprise one or more these pentapeptides which make up the 3-dimensional nanofibrous network of the hydrogel structure. The hydrogels are shear-thinning hydrogels that have high storage moduli and high rates of recovery after destruction.Type: ApplicationFiled: October 31, 2019Publication date: August 25, 2022Applicant: UNIVERSITY OF VIRGINIA PATENT FOUNDATIONInventors: Kyle Jay LAMPE, James D. TANG
-
Patent number: 11419948Abstract: Ultra-low crosslinked microgels made of an ultra-low crosslinked polymer are provided. The microgels, also referred to as Platelet-like Particles (PLPs), preferably have <0.5% crosslinking densities. One or more of the polymers are conjugated with a fibrin-binding element or moiety, preferably H6, in an amount effective to confer to the microgel selective binding to fibrin under physiological conditions. The PLPs can recapitulate multiple key functions of platelets including binding, stabilizing and enhancing fibrin clot formation, responsiveness to injury cues, and induction of clot contraction. In a preferred embodiment, the microgel or PLP has little or no binding to soluble fibrinogen under physiological conditions compared to its binding to fibrin. The microgels or PLPs are prepared using crosslinker-free synthesis conditions, and can promote or induce clotting and clot contraction.Type: GrantFiled: February 4, 2019Date of Patent: August 23, 2022Assignees: Georgia Tech Research Corporation, University of Virginia Patent Foundation, North Carolina State UniversityInventors: Thomas H. Barker, Ashley Carson Brown, Louis Andrew Lyon, Sarah E. Stabenfeldt, Nicole Welsch, John Nicosia
-
Publication number: 20220257604Abstract: Provided are methods and compositions for inhibiting viral infections. In some embodiments, the methods include administering to a subject infected with and/or at risk for infection with a virus a composition having a glucosylceramidase inhibitor, a glucosylceramide synthase inhibitor, or any combination thereof via a route and in an amount effective for treating and/or inhibiting the viral infection in the subject. Also provided are methods for inhibiting viral infections of cells, methods for inhibiting endosomal fusion of viruses in cells, and compositions for use in treating and/or inhibiting viral infections of subjects and/or cells.Type: ApplicationFiled: March 9, 2020Publication date: August 18, 2022Applicant: University of Virginia Patent FoundationInventors: Mark Kester, Kelly C. Drews
-
Publication number: 20220257199Abstract: Embodiments relate to an adaptive glycemia monitoring and forecasting system that includes an event monitor configured to receive blood glucose levels of an individual or information about an activity performed by the individual, and generate an event output. The system includes a control module configured to pull observation data, predictor variables, and population estimated vector of covariate weightings coefficients from a database, and generate updated estimated vector of covariate weightings coefficients for the individual user based on the event output. The updated estimated vector of covariate weightings coefficients are determined by a cross-entropy loss objective function. The updated estimated vector of covariate weightings coefficients are used to predict at least one or more of a predicted hypoglycemia state, a predicted normal glycemia state, or a predicted hyperglycemia state for the individual user.Type: ApplicationFiled: July 10, 2020Publication date: August 18, 2022Applicant: UNIVERSITY OF VIRGINIA PATENT FOUNDATIONInventors: Marc D. BRETON, Jonathan HUGHES, Stacey ANDERSON
-
Patent number: 11413324Abstract: During development, OPCs migrate extensively throughout the spinal cord, but their migration is restricted at transition zones (TZ). At these specialized locations, unique glial cells in both zebrafish and mice are at least partially responsible for preventing peripheral OPC migration, but the mechanisms of this regulation are not understood. In order to elucidate the signals that mediate OPC segregation at motor exit point (MEP) TZs, we performed an unbiased small molecule screen. Using chemical screening and in vivo imaging, we discovered that inhibition of A2a adenosine receptors (AR) causes ectopic OPC migration out of the spinal cord. In our studies, we provide in vivo evidence that endogenous neuromodulation by adenosine regulates OPC migration along motor axons, specifically at the MEP TZ. This work opens exciting possibilities for understanding how OPCs reach their final destinations during development and identifies mechanisms that could promote their migration in disease.Type: GrantFiled: March 16, 2018Date of Patent: August 16, 2022Assignee: University of Virginia Patent FoundationInventors: Sarah Kucenas, Taylor Welsh
-
Patent number: 11415655Abstract: Some aspects of the present disclosure relate a method for magnetic resonance imaging, which can include acquiring, by applying an imaging pulse sequence, magnetic resonance data associated with a region of interest of a subject. The imaging pulse sequence can include a plurality of RF pulses configured to generate a desired image contrast, and an outer-volume suppression (OVS) module to attenuate the signal outside the region of interest. The method can further include reconstructing, from the acquired magnetic resonance data, a plurality of reduced field of view (rFOV) magnetic resonance images corresponding to the region of interest.Type: GrantFiled: May 26, 2017Date of Patent: August 16, 2022Assignees: UNIVERSITY OF VIRGINIA PATENT FOUNDATION, BETH ISRAEL DEACONESS MEDICAL CENTER, INC.Inventors: Michael Salerno, Yang Yang, Li Zhao, Xiao Chen
-
Patent number: 11413449Abstract: This invention provides an device for electrical stimulation of the spinal cord. The device has an electrode assembly with a sufficiently thin profile to be implanted between the pial surface of the spinal cord and the dura mater, and secured to the dura. Electrodes on the electrode assembly are directed towards the surface of the spinal cord, and connected through the dura to a signal generator located outside the dura. Following implantation, the subject is treated by transmitting electrical signals from the signal generator through the leads to the electrodes, stimulating the subject's spinal cord.Type: GrantFiled: February 13, 2020Date of Patent: August 16, 2022Assignees: UNIVERSITY OF IOWA RESEARCH FOUNDATION, University of Virginia Patent FoundationInventors: Matthew A. Howard, Timothy Brennan, Brian Dalm, Marcel Utz, George T. Gillies, Steven Scott, Randall S. Nelson, Robert Shurig
-
Publication number: 20220251085Abstract: Purine-derived covalent probes (e.g., halo or di-halo-substituted purine based covalent probes) and related ligands are described. The compounds can be used to identify reactive nucleophilic amino acid residues, such as reactive cysteine residues, in proteins and to modify the activity of proteins with reactive nucleophilic amino acid residues (e.g., reactive cysteine residues) via the formation of protein adducts comprising the ligands Modified proteins prepared from the probes and ligands are also described.Type: ApplicationFiled: July 21, 2020Publication date: August 11, 2022Applicant: University of Virginia Patent FoundationInventors: Ku-Lung Hsu, Adam Libby, Andy Heindel, Jeffrey W. Brulet, Boobalan Pachaiyappan
-
Publication number: 20220249366Abstract: The invention relates generally to methods of using a thiol-Michael addition hydrogel for providing intracavitary brachytherapy and/or displacing tissue and organs. The thiol-Michael addition hydrogel may be used as a packing material and an attenuation material for intracavitary brachytherapy applications. The invention also relates generally to a brachytherapy applicator, which may be used in conjunction with the thiol-Michael addition hydrogel and methods thereof. The invention also relates to a positioning device system for providing intracavitary brachytherapy treatment and a kit thereof.Type: ApplicationFiled: January 18, 2022Publication date: August 11, 2022Applicants: UNIVERSITY OF VIRGINIA PATENT FOUNDATION, VIRGINIA TECH INTELLECTUAL PROPERTIES, INC.Inventors: Timothy Norman SHOWALTER, Timothy E. LONG, Nicholas MOON
-
Patent number: 11408959Abstract: A positioning system and method includes a transmitter, a receiver, and a controller. The transmitter includes at least one energy source configured to emit an optical or quasi-optical electromagnetic signal as a channel communication. The receiver includes at least one detector element configured to receive the channel communication. The controller is connected to the receiver and configured to estimate a position of the transmitter within a space using a reference map of the space and one or more diffuse components of an impulse response of the channel communication.Type: GrantFiled: December 21, 2018Date of Patent: August 9, 2022Assignee: University of Virginia Patent FoundationInventors: Maite Brandt-Pearce, Hamid Hosseinianfar, Mohammad Noshad
-
Patent number: 11406313Abstract: A system for classifying cardiac rhythms is disclosed. The system includes one or more processors, one or more computer-readable tangible storage devices, and program instructions stored on at least one of the one or more storage devices for execution by at least one of the one or more processors. The program instructions include first program instructions to obtain data representative of a time series of the times between heartbeats. The program instructions further comprise second program instructions to segment the time series into a plurality of segments. The program instructions further comprise third program instructions to calculate a plurality of parameters corresponding to each of the 30-second segments. The program instructions further comprise fourth program instructions to analyze the obtained data and the calculated parameters using a plurality of multivariable algorithms for rhythm classification.Type: GrantFiled: June 17, 2015Date of Patent: August 9, 2022Assignee: UNIVERSITY OF VIRGINIA PATENT FOUNDATIONInventors: J. Randall Moorman, Douglas E. Lake
-
Patent number: 11411435Abstract: An integrated circuit, such as included as a portion of a sensor node, can include a regulator circuit having an input coupleable to an energy harvesting transducer. The integrated circuit can include a wireless receiver circuit coupled to the regulator circuit and configured to wirelessly receive at least enough operating energy to establish operation of the sensor node without requiring the energy harvesting transducer. The integrated circuit can include a digital processor circuit coupled to the regulator circuit and a power management processor circuit. The digital processor circuit or one or more other circuits can include a subthreshold operational mode established by the power management processor circuit based on the selected energy consumption level. For example, establishing the subthreshold operational mode can include adjusting or selecting a supply voltage so as to establish subthreshold operation of a field effect transistor (FET) in the digital processor circuit or other circuits.Type: GrantFiled: November 25, 2019Date of Patent: August 9, 2022Assignees: University of Virginia Patent Foundation, University of Washington through its Center for CommercializationInventors: Benton H. Calhoun, Brian Otis